by wheelel23 | Sep 25, 2014 | News
Trinity Biotech plc. (Nasdaq: TRIB), today announced it has obtained the CE mark (i.e. European approval) for its Meritas point-of-care BNP test. Heart failure, also referred to as chronic or congestive heart failure, is a complex progressive syndrome that impacts...
by wheelel23 | Jul 1, 2014 | News
Trinity Biotech plc announces the CE marking of our new Uni-Gold™ H. pylori Antigen point-of-care test. The Uni-Gold™ H. pylori Antigen is a 15 min rapid test, used to aid in the diagnosis of Helicobacter pylori (H. pylori) infection and to monitor the effectiveness...
